Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Famotidine does not affect indocyanine green disposition and serum bile acid levels in healthy subjects.

Literature DB >> 2886146

Famotidine does not affect indocyanine green disposition and serum bile acid levels in healthy subjects.

R Testa, A Grasso, F Dagnino, R Ibba, G Varagona, G Celle.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1987 PMID： 2886146 PMCID： PMC1386177

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

9 in total

1. SPECTROPHOTOMETRIC DETERMINATION OF INDOCYANINE GREEN IN PLASMA ESPECIALLY WITH A VIEW TO AN IMPROVED CORRECTION FOR BLANK DENSITY.

Authors: N C NIELSEN
Journal: Scand J Clin Lab Invest Date: 1963 Impact factor: 1.713

2. Comparative effects of famotidine and cimetidine on antipyrine kinetics in healthy volunteers.

Authors: C Staiger; B Korodnay; J X Devries; E Weber; P Müller; B Simon; H G Dammann
Journal: Br J Clin Pharmacol Date: 1984-07 Impact factor: 4.335

3. Fasting serum bile acid level in cirrhosis. A semi-quantitative index of hepatic function.

Authors: S Islam; R E Poupon; J C Barbare; Y Chrétien; F Darnis; R Poupon
Journal: J Hepatol Date: 1985 Impact factor: 25.083

4. Famotidine, a new H2-receptor antagonist, does not affect hepatic elimination of diazepam or tubular secretion of procainamide.

Authors: U Klotz; P Arvela; B Rosenkranz
Journal: Eur J Clin Pharmacol Date: 1985 Impact factor: 2.953

5. Clearance and non-invasive determination of the hepatic extraction of indocyanine green in baboons and man.

Authors: S L Grainger; P W Keeling; I M Brown; J H Marigold; R P Thompson
Journal: Clin Sci (Lond) Date: 1983-02 Impact factor: 6.124

6. Half-life time or clearance of indocyanine green in patients with liver disease.

Authors: I T Gilmore; J H Marigold; R P Thompson
Journal: Hepatogastroenterology Date: 1982-04

7. Serum bile acid determination after different doses of orally ingested chenodeoxycholic acid. Evaluation of a simplified enzymatic method.

Authors: H Tanghöj; U Foberg; A Frydén; B Kågedal; L Pettersson; P Tobiasson
Journal: Scand J Gastroenterol Date: 1985-12 Impact factor: 2.423

8. Effect of famotidine on oxidative drug metabolism.

Authors: K W Somerville; G A Kitchingman; M J Langman
Journal: Eur J Clin Pharmacol Date: 1986 Impact factor: 2.953

9. Intestinal solubilization, absorption, pharmacokinetics and bioavailability of chenodeoxycholic acid.

Authors: M Ponz de Leon; P Loria; N Carulli; G M Murphy; R H Dowling
Journal: Eur J Clin Invest Date: 1980-08 Impact factor: 4.686

9 in total

7 in total

Review 1. Haematological adverse effects of histamine H2-receptor antagonists.

Authors: J P Aymard; B Aymard; P Netter; B Bannwarth; P Trechot; F Streiff
Journal: Med Toxicol Adverse Drug Exp Date: 1988 Nov-Dec

Review 2. Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors: K Lauritsen; L S Laursen; J Rask-Madsen
Journal: Clin Pharmacokinet Date: 1990-08 Impact factor: 6.447

Review 3. Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.

Authors: H D Langtry; S M Grant; K L Goa
Journal: Drugs Date: 1989-10 Impact factor: 9.546